3rd Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$105,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Korea US Free Trade Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI L WAGNER | — |
Health Issues HCR
Monitor implementation of PPACA, including provisions relating to orphan drugs and regulatory pathway for biosimilars. Monitor deficit reduction initatives, including Budget Control Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.